Skip to main content
Aarti Pharmalabs Limited logo

Aarti Pharmalabs Limited — Investor Relations & Filings

Ticker · AARTIPHARM ISIN · INE0LRU01027 LEI · 335800TTAKRBNDK5P363 BSE.NS Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2025-10-13 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS AARTIPHARM

About Aarti Pharmalabs Limited

https://www.aartipharmalabs.com/

Aarti Pharmalabs Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives. The company specializes in the development and production of complex chemistry-based products for the global pharmaceutical and generic drug industries. Its core portfolio includes APIs across diverse therapeutic areas such as oncology, cardiovascular, and anti-diabetics. Additionally, the company is a major producer of xanthines, including caffeine and theophylline. Aarti Pharmalabs offers comprehensive Contract Development and Manufacturing Organization (CDMO) services, leveraging its integrated research and development capabilities and large-scale manufacturing facilities. The organization maintains high regulatory standards, ensuring compliance with international quality benchmarks to serve a global clientele.

Recent filings

Filing Released Lang Actions
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the allotment of equity shares pursuant to the exercise of stock options under the company's Performance Stock Option Plan 2023 (PSOP 2023). It details the number of shares allotted, exercise price, updated paid-up capital, and compliance with SEBI regulations. The document is a formal announcement of a share allotment event and capital change, not a financial report or detailed analysis. It does not contain financial statements or management discussion but rather informs about a capital change due to stock option exercise. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is 5362 characters, which is sufficient for a detailed announcement rather than a brief notice. Hence, the classification is SHA with high confidence.
2025-10-13 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges regarding an ex-parte ad-interim injunction order received from the High Court of Delhi. It informs about a legal action restraining the company from certain activities related to a pharmaceutical product due to patent infringement allegations. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is a regulatory announcement about a legal proceeding affecting the company, not a full legal proceedings report or financial report. It is not a full audit, annual, or interim report, nor a call transcript or earnings release. The document is a regulatory filing informing the market about a significant legal event as required by listing regulations. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is 3530 characters, which is relatively short and consistent with a regulatory announcement rather than a full report.
2025-10-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended September 30, 2025. It is addressed to stock exchanges and signed by the company secretary and the registrar and share transfer agent. The content is a compliance certificate related to securities dematerialisation and does not contain financial statements or detailed financial data. It is a regulatory compliance filing rather than a financial report or announcement of voting results, management changes, or capital changes. The document length is short (3012 characters) and primarily serves as a certification under a regulatory requirement. Therefore, it fits best under Regulatory Filings (RNS).
2025-10-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the closure of the trading window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs about the trading window closure from October 1, 2025, until 48 hours after the declaration of financial results for the quarter ending September 30, 2025. There is no financial data, report, or detailed analysis included. The document is a regulatory announcement related to compliance and insider trading rules, not a financial report or earnings release. It is short (1522 characters) and serves as a notification to the exchanges. Therefore, it fits best under Regulatory Filings (RNS).
2025-09-25 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is an investor presentation made to shareholders at the 6th Annual General Meeting held on September 22, 2025. It includes company overview, key milestones, business segments, quarterly revenue break-up, and detailed financial highlights including standalone and consolidated income statements with multiple years of data. The document is lengthy (over 14,000 characters) and contains detailed financial data and business information, typical of an investor presentation. The cover letter explicitly states it is an "Investor Presentation" submitted under Regulation 30 of SEBI (LODR) Regulations 2015. There is no indication that this is the full Annual Report (10-K) or a standalone audit report, nor is it a transcript, call, or voting result. Therefore, the most appropriate classification is Investor Presentation (IP).
2025-09-23 English
Change in Management
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding changes in management following the 6th Annual General Meeting (AGM) held on September 22, 2025. It reports the re-appointment of an Independent Director and the appointment of a Secretarial Auditor, referencing Regulation 30 of SEBI (LODR) Regulations, 2015, which governs disclosure of material events including management changes. The document includes detailed profiles of the appointees and the terms of their appointments. It is not a full annual report or financial statement but an announcement of management changes post-AGM. The document length is 4571 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. Therefore, the appropriate classification is Board/Management Information (MANG).
2025-09-23 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.